Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples